Riversedge Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,219
Closed -$232K – 73
2022
Q1
$232K Buy
3,219
+525
+19% +$37.8K 0.08% 60
2021
Q4
$247K Buy
2,694
+565
+27% +$67.5K 0.08% 58
2021
Q3
$270K Buy
2,129
+907
+74% +$132K 0.09% 54
2021
Q2
$203K Buy
+1,222
New +$198K 0.07% 51
2021
Q1
– Sell
-3,906
Closed -$781K – 50
2020
Q4
$781K Buy
3,906
+114
+3% +$23.2K 0.36% 27
2020
Q3
$831K Buy
3,792
+322
+9% +$68.2K 0.44% 26
2020
Q2
$662K Buy
3,470
+1,251
+56% +$219K 0.39% 25
2020
Q1
$344K Sell
2,219
-1,817
-45% -$211K 0.3% 27
2019
Q4
$338K Hold
4,036
– – 0.4% 28
2019
Q3
$223K Hold
4,036
– – 0.31% 34
2019
Q2
$223K Buy
+4,036
New +$235K 0.31% 34

Other funds holding TDOC

Riversedge Advisors's TDOC Position: Q2 2022 in Review

Riversedge Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,219 shares — an estimated $232K sold.

Riversedge Advisors first reported a position in TDOC in Q2 2019 and held it in 11 quarters. The position peaked at $831K in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Riversedge Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Riversedge Advisors sold 3,219 Teladoc Health shares in Q2 2022, an estimated $232K.
  • Riversedge Advisors first reported a position in Teladoc Health in Q2 2019 and held it in 11 quarters.
  • Riversedge Advisors's Teladoc Health position peaked at $831K in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Riversedge Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.